Clinical Trial Update: SOLX Gold Shunt for Refractory Glaucoma [NA]

View source ↗

Summary

The clinical trial evaluating the SOLX Gold Shunt for refractory glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• SOLX Gold Shunt

Snippet

Sponsor: SOLX, Inc. | Conditions: Glaucoma, Glaucoma, Open Angle | NA | Status: COMPLETED